<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>BioScreening - organic compounds for screening</title>
<link>http://www.bioscreening.com/index/</link>
<description>Business Directories of Suppliers for Chemicals for Bioscreening and Combinatorial Chemistry, Databases for Drug Discovery, Test systems for Screening of Tubulin modulators, Custom Synthesis and other Biotech Industries</description>
<generator>BBDMS 1.0.0</generator>
<managingEditor>info@bioscreening.com (Somebody)</managingEditor>
<webMaster>info@bioscreening.com (Somebody)</webMaster>
<pubDate>Thu, 11 Mar 2010 18:26:10 -0500</pubDate>
<lastBuildDate>Thu, 11 Mar 2010 18:26:10 -0500</lastBuildDate>
<language>en</language>
<copyright>Copyright by Somebody</copyright>
<item>
<title>MALDI-Based Method May Reduce Cost of Rx-Screening Assays, Speed Drug Development</title>
<link>http://www.bioscreening.net/2009/10/20/maldi-based-method-may-reduce-cost-of-rx-screening-assays-speed-drug-development/</link>
<description>
<![CDATA[ This story originally ran on Oct. 6.
By Tony Fong
Researchers from the University of Cincinnati and MDS Analytical Technologies have used mass spectrometry to develop a high-throughput screening method for drug discovery they say can be more precise and cost-effective than existing techniques.
The technique is based on a MALDI triple-quadrupole platform and exploits the selective multiple-reaction ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Thu, 22 Oct 2009 11:11:00 -0400</pubDate>
</item>
<item>
<title>Scripps Research scientists awarded $3.9 million grant to develop new compound screening platform</title>
<link>http://www.bioscreening.net/2009/10/20/scripps-research-scientists-awarded-39-million-grant-to-develop-new-compound-screening-platform/</link>
<description>
<![CDATA[ Bicoastal effort could help revolutionize the search for new therapies
La Jolla, CA, and Jupiter, FL, October 5, 2009 –A pair of scientists from The Scripps Research Institute, one on each coast, has been awarded a five-year $3.9 million grant from the National Institutes of Health (NIH) to develop a new technology to accelerate the search ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Thu, 22 Oct 2009 11:11:00 -0400</pubDate>
</item>
<item>
<title>BioServe to Test for Swine Flu in India</title>
<link>http://www.bioscreening.net/2009/10/22/bioserve-to-test-for-swine-flu-in-india/</link>
<description>
<![CDATA[ Beltsville, MD; and Hyderbad, AP, India, October 21, 2009 – BioServe, a leading provider of clinical bio-samples and research services, today announced that it has been selected by the Government of the State of Andhra Pradesh in India and The Institute of Preventive Medicine (IPM) Hyderabad as one of two private diagnostic centers to test ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Thu, 22 Oct 2009 11:11:00 -0400</pubDate>
</item>
<item>
<title>Trophos launches the new generation of its fast plate imaging instrument, the Plate RUNNER HD</title>
<link>http://www.bioscreening.net/2009/10/12/trophos-launches-the-new-generation-of-its-fast-plate-imaging-instrument-the-plate-runner-hd/</link>
<description>
<![CDATA[ Marseille, FRANCE, 2009 September 29 - Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology, announced today the launch of the new generation of its fluorescence ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Thu, 22 Oct 2009 11:10:00 -0400</pubDate>
</item>
<item>
<title>AIDS Study Flushes Out Hidden Virus, Pointing to Possible Cure</title>
<link>http://www.bioscreening.net/2009/10/14/aids-study-flushes-out-hidden-virus-pointing-to-possible-cure/</link>
<description>
<![CDATA[ Oct. 2 (Bloomberg) — Scientists, moving closer to a cure for AIDS, identified a way to find medicines that would help rid patients of the hardest-to-treat pockets of HIV.
Current anti-HIV drugs reduce the virus to undetectable levels without eradicating it. The virus survives by lying dormant in immune-system cells, where the medicines don’t reach them. ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Thu, 22 Oct 2009 11:10:00 -0400</pubDate>
</item>
</channel>
</rss>
